chronic interstitial cystitis
Information
- Disease name
- chronic interstitial cystitis
- Disease ID
- DOID:1678
- Description
- "A chronic cystitis characterized by unpleasant sensation related to the bladder and lower urinary tract in the absence of identifiable causes and has_symptom pain, has_symptom pressure, has_symptom discomfort, has_symptom dysuria, and/or has_symptom urinary frequency." [url:https\://en.wikipedia.org/wiki/Interstitial_cystitis, url:https\://www.mayoclinic.org/diseases-conditions/interstitial-cystitis/symptoms-causes/syc-20354357]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01879683 | Completed | Phase 1 | A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions | July 2013 | June 2014 |
| NCT02331472 | Completed | The Efficacy of Urine Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (Pilot Study) | February 3, 2015 | January 14, 2016 | |
| NCT04275297 | Completed | N/A | Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome | July 13, 2020 | June 16, 2023 |
| NCT04540887 | Completed | N/A | PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome | February 24, 2021 | November 30, 2021 |
| NCT05744908 | Completed | N/A | Pentosan Polysulfate Treatment's Effectiveness | January 1, 2018 | January 10, 2023 |
| NCT06013449 | Not yet recruiting | N/A | Efficacy of Pulsed Electromagnetic Field and Heparin/Bupivacaine Instillations | July 2024 | January 2025 |
| NCT04734106 | Not yet recruiting | Early Phase 1 | Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis | July 2024 | October 2024 |
| NCT05149573 | Recruiting | N/A | Investigation of PEMF Therapy for Female Patients With IC/BPS | August 29, 2022 | April 2025 |
| NCT06299683 | Recruiting | N/A | Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment | May 1, 2024 | August 4, 2028 |
| NCT03143920 | Terminated | Early Phase 1 | Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder | November 1, 2017 | July 7, 2022 |
| NCT02858453 | Unknown status | Phase 3 | Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome | July 2016 | February 2020 |
- Disase is a (Disease Ontology)
- DOID:1680
- Cross Reference ID (Disease Ontology)
- ICD10CM:N30.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:595.1
- Cross Reference ID (Disease Ontology)
- MESH:D018856
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:44497007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0600040